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fever with or without chills, chest tight-
ness, dry cough, and shortness of breath, 
while developing patchy to diffuse infil-
tration of the lungs, as shown radio-
graphically in Figure  1. Identifying and 
monitoring SARS-CoV-2 infection has 
become crucially important. A recent pro-
jection of the transmission dynamics of 
SARS-CoV-2[2] showed that longitudinal 
serological studies are desperately needed 
to determine the extent and duration of 
immunity to SARS-CoV-2. Even in the 
event of apparent elimination, mainte-
nance of SARS-CoV-2 surveillance is still 
needed because of a possible resurgence 
of contagion.
In the past, notable viruses have 
emerged suddenly from obscurity or 
anonymity, provoking concern from the 
point of view of immunology regarding 
their sustained epidemic transmis-
sion in naive human populations. More 
than 70% of these infections have been 
zoonotic, entering either directly from 
wild animal reservoirs or indirectly via an intermediate 
domestic animal host.[3] Ebola virus, avian influenza, human 
immunodeficiency virus (HIV), and SARS are all examples of 
zoonoses that have emerged from wild animals, presenting an 
increasingly serious threat to human health and economies 
worldwide. Figure 2 shows the trend in the number of people 
infected with SARS-CoV-2.[4]
The spread of the severe acute respiratory syndrome coronavirus has 
changed the lives of people around the world with a huge impact on eco-
nomies and societies. The development of wearable sensors that can con-
tinuously monitor the environment for viruses may become an important 
research area. Here, the state of the art of research on biosensor materials 
for virus detection is reviewed. A general description of the principles for 
virus detection is included, along with a critique of the experimental work 
dedicated to various virus sensors, and a summary of their detection limita-
tions. The piezoelectric sensors used for the detection of human papilloma, 
vaccinia, dengue, Ebola, influenza A, human immunodeficiency, and hepatitis 
B viruses are examined in the first section; then the second part deals with 
magnetostrictive sensors for the detection of bacterial spores, proteins, 
and classical swine fever. In addition, progress related to early detection of 
COVID-19 (coronavirus disease 2019) is discussed in the final section, where 
remaining challenges in the field are also identified. It is believed that this 
review will guide material researchers in their future work of developing 
smart biosensors, which can further improve detection sensitivity in moni-
toring currently known and future virus threats.
1. Introduction
In December 2019, an acute febrile illness with a severe res-
piratory distress syndrome began to appear, and an evolving 
situation was reported involving infection with a novel corona-
virus, named severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2).[1] Most patients with SARS-CoV-2 experience 
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Early assessment of etiologic agents, such as viruses, is 
imperative for clinical point of care (POC). In medical diagnos-
tics, virus recognition can be performed in laboratories using 
traditional methods, such as polymerized chain reaction (PCR) 
amplification and enzyme-linked immunoassays, both of which 
require biological labels, such as radioisotopes, enzymes, and 
fluorophores, which can be readily detected using various ana-
lytical techniques. Although these methods are extremely sensi-
tive and selective, it is common to employ multiple detection 
layers for several analytes. The need to engage highly trained 
staff, long analytical times, and the huge investment in effort 
and resources often hamper diagnosis. Considering the dif-
ferent diagnostic applications, there is an urgent need for effec-
tive virus sensors that are small and easy to operate and offer 
rapid response times as well as high selectivity, cross-sensitivity, 
and portability.[5]
Biosensors are described as compact analytical devices, incor-
porating biological or biomimetic sensing elements, and are 
applied for the detection and monitoring of various analytes or 
pathogens that are important for the environment, health, and 
food industries.[6] Biosensors must meet the requirements of 
sensitivity, response accuracy, reproducibility, high specificity 
toward the desired target element, nontoxicity, and cost-effec-
tiveness.[7] Biosensors can be divided into various groups, such 
as optical, piezoelectric, and electrochemical. Figure 3 presents 
an overview of the main approaches using transducers in bio-
sensors. The simplest type of biosensor is an optical trans-
ducer,[8] which can detect the analyte or pathogen as a measured 
change in the fluorescence, absorption, or reflectance perfor-
mance of the sensing material. Figure  3a shows the fluores-
cence spectra of a semiconducting polyelectrolyte nanocomplex 
with and without exosomes (Exo.), as involved in pathogenesis-
including neurodegenerative diseases, viral/bacterial infections, 
and cancer. This technique simply takes advantage of the color 
change of the sensing materials when their size or concentration 
changes due to interaction with the analyte or pathogen. The 
second class of biosensors is the micromechanical transducer; 
the basis of this method is the measurement of changes in the 
resonance frequency.[5] Quartz crystal microbalance (QCM) 
with piezoelectric properties, benefits from frequency changes 
(see Figure 3b) or deflection of the sensing material. The third 
class of biosensors is the electrochemical biosensor, which can 
be classified as amperometric, potentiometric, impedimetric, 
or conductometric.[9,10] Figure 3c shows a schematic illustration 
of an electrochemical sensor and the responses of square-wave 
voltammetry of this sensor at concentrations of 0, 4, 6, 8, and 
10  ng mL−1 of total prostate-specific antigen (PSA). Graphene 
oxide/Au nanoparticles/antitotal PSA antibody is attached to 
Figure 1. Chest computerized tomography images of patients with novel coronavirus pneumonia. a) Patchy ground-glass-like density change from a 33 year 
old patient who developed a mild illness after exposure at work and b) bilateral diffuse thickening of interlobular septa with network-like densities, bron-
chiolar thickening, and consolidation of the left lower lobe in an 83 year old patient. Reproduced with permission.[1] Copyright 2020, Wiley Periodicals, Ltd.
Figure 2. Accumulated confirmed SARS-CoV-2 infections as of July 27, 2020. Reproduced with permission.[4] Copyright 2020, Johns Hopkins University.
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the surface of the working electrode for antigen capture. The 
resulting antigen/antibody-modified electrode is subsequently 
incubated with the prepared graphene oxide/Au nanoparticles/
anti-free PSA antibody to form a sandwich-like system. The 
limit of detection of this biosensor is related to the large specific 
surface area of graphene oxide and the high electrochemical 
current of Au. It should be noted that in addition to the above 
three biosensors, other devices such as microfluidic,[11] plas-
monic,[12] cantilever-based[13,14] and field-effect transistor (FET)-
based electronic[15,16] biosensors have been developed.
Regarding the coronavirus disease 2019 (COVID-19) 
pandemic that has never been experienced before in the 21st 
century, Ji et  al.[17] summarized the structure of SARS-CoV-2, 
its genomic and gene expression characteristics, the current 
progress of SARS-CoV-2 ribonucleic acid (RNA), antibodies, 
antigens, and virus detection. Morales-Narváez and Dincer[18] 
outlined innovative diagnostic methods for targeting a variety 
of COVID-19-related biomarkers. By measuring prognostic bio-
markers and combining this knowledge with clinical observa-
tions and risk factors, patients can be stratified according to dis-
ease severity, so Russell et al.[19] proposed the ideal features of 
the biosensors that can be regarded as a key player in precision 
medicine for COVID-19. On the other hand, research and devel-
opment of biosensors that can detect at an early stage with high 
sensitivity and low cost have been conducted. However, none of 
these are commercially available on the market, and cannot be 
used for pandemic diseases such as COVID-19.[20] Seven main 
recommendations have been suggested to the biosensing com-
munity (Figure 4).[18,20] Recently, Samson et al.[21] highlighted an 
overview of the traditional viral detection methods, and recent 
trends and future perspectives of biosensors for the detection of 
SARS-CoV-2.
Herein, the emphasis is on the piezoelectric materials since 
their coupled electromechanical properties[22] make them well-
suited for use as sensors and actuators in smart structures and 
devices. In the past two decades, a wide range of piezoelectric 
ceramics and composites[23,24] have been studied by the Tohoku 
University research group. Piezoelectric materials have also 
become important biomaterials that can be interfaced with 
biological tissues and used in miniaturized bioelectronic and 
biochemical devices.[25] Meanwhile, magnetostrictive materials 
can convert magnetic energy into mechanical energy or the 
reverse,[26,27] and are used to build sensors and actuators. In the 
past decade, works on magnetostrictive alloys and composites, 
including clad plates,[28] short wire composites,[29] and long wire 
composites,[30] have been reported by our group. A new type of 
active magnetostrictive material has also been introduced as a 
biological sensor platform[31] in recent years.
Piezoelectric ceramics/polymers and magnetostrictive 
alloys are examples of functional materials, which are promi-
sing energy-harvesting materials.[32,33] Functional composite 
materials and energy-harvesting technologies play an important 
role in building the Internet of Things (IoT) society.[34–36] After the 
SARS-CoV-2 pandemic, environmental monitoring will become 
even more important. Also expected to gain importance is detec-
tion and monitoring of damage in composite materials[37,38]  
using electromagnetic sensors. Indeed, it is desirable to 
develop virus sensors that do not require power sources or 
Figure 3. a) An overview of the main approaches using an optical biosensor. b) A piezoelectric biosensor. c) An electrochemical biosensor. a) Repro-
duced with permission.[8] Copyright 2019, Wiley-VCH. b) Reproduced under the terms of the CC-BY Creative Commons Attribution 4.0 International 
license (https://creativecommons.org/licenses/by/4.0).[5] Copyright 2017, The Authors, published by MDPI. c) Reproduced with permission.[9] Copyright 
2019, Wiley-VCH.
Adv. Mater. 2020, 2005448
www.advmat.dewww.advancedsciencenews.com
2005448 (4 of 24) © 2020 The Authors. Advanced Materials published by Wiley-VCH GmbH
batteries. Piezoelectric and magnetostrictive biosensors seem to 
exhibit superior performance to that of other biosensors (see 
Table  1).[39,40] Optimal composite design will also ensure that 
the piezoelectric and magnetostrictive biosensors meet the 
requirements illustrated in Figure 4. However, further research 
progress is required; although the piezoelectric and magneto-
strictive sensors can detect the viruses from frequency changes, 
these sensors have a potential to detect directly using the 
output voltage. In addition, they are expected to be combined 
with piezoelectric and magnetostrictive energy-harvesting 
devices for the IoT, with the possibility to identify viruses by 
monitoring mechanical vibration. They can also be attached 
or embedded in smart clothing. Herein, we briefly discuss 
several human viruses with the main focus on piezoelectric 
and magnetostrictive materials of a layered configuration and 
energy-harvesting capabilities, aiming to provide insights into 
the development of more sensitive virus sensors. Attention is 
drawn to the sensor material itself, whereas the receptor linked 
to the sensor that confers specificity to the detection is out of 
scope for the present review.
2. Piezoelectric Biosensors
A piezoelectric material exhibits a mechanical oscillation under 
an alternating current (AC) voltage, producing an oscillating 
electric field. When a mass m increases due to the interac-
tions between molecules, the frequency f controlled by the AC 
voltage decreases. Mass response-type piezoelectric sensors are 
commonly used for virus detection. A schematic illustration of 
the operation principle of the piezoelectric biosensor is shown 
in Figure 5. Probe antibodies are fixed on the upper electrode 
surface of the piezoelectric material as shown in Figure 5a. The 
upper and lower electrodes drive the resonation of the piezo-
electric material. Target antigen then binds with the probe anti-
bodies. The mass change Δm on the electrode surface leads to 
a time-dependent frequency shift (see Figure 5b) that is repre-
sented by the frequency change Δf (Figure  5c) of the material 
in the oscillation circuit.[41] Mainly anisotropic materials such 
as aluminum nitride (AlN),[42–44] zinc oxide (ZnO),[45,46] barium 
titanate (BaTiO3),[47–49] lead titanate (PbTiO3),[50–52] quartz 
(SiO2),[53,54] and poly(vinylidene fluoride) (PVDF)[55,56] are used 
as sensor materials.[57] Table  2 lists the Young’s modulus E, 
shear modulus μ, Poisson’s ratio ν, mass density ρ, longitu-
dinal piezoelectric coefficient d33, and transverse piezoelectric 
coefficient d31 of each of these materials.
Sauerbrey[58] discovered the relation between the quartz 
oscillation frequency in thickness shear mode and change in 
surface mass. The Sauerbrey equation is given by Equation (1)
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Figure 4. Seven main recommendations for the biosensing community and ten requirements for biosensing devices detecting infectious diseases.
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where f0 is the fundamental resonance frequency and A is the 
active area of the piezoelectric material. The QCM technique, a 
label-free technology, has made great progress[59] and has been 
successfully applied in virus detection. QCM can exhibit extraor-
dinary sensitivity to changes in resonance frequency, recording 
sub-nanogram mass changes. The performance of the QCM is 
characterized using the mass sensitivity, which describes the 
shift in resonance frequency f0 due to adsorption of virus par-
ticles and the mechanical quality factor (Q value) defining the 







where Δs is defined as the spread of the signal trace at a dis-
tance from the baseline equal to the magnitude divided by 2. 
A higher Q value means a sharper resonance peak, resulting 
in a higher precision in determining resonance frequency and 
a smaller minimum detectable frequency change. The Q value 
can be optimized by the sensor electrode size and shape.[60] 
Figure 6 shows three different AT-cut 10  MHz quartz crystals 
together with the corresponding Q values in air and in a liquid 
environment.
Cantilever beams of microscale length and width and 
nanoscale thickness are also used as resonant sensors to detect 
a variety of biological and chemical entities.[13] The resonance 








where m* = 0.24ρlwh and k  = Eh3w/(4l3) are the mass and 
spring constants of the cantilever, respectively, expressed as 
functions of the density ρ, Young’s modulus E, length l, width 
Figure 5. Basic concept of virus detection using piezoelectric material. a) Operation principle of a piezoelectric biosensor; b,c) schematics of voltage 
to time (b) and amplitude to frequency (c) during detection.
Table 2. Engineering constants of piezoelectric materials.
E [GPa] μ [GPa] ν ρ [g cm−3] d33 [pC N−1] d31 [pC N−1]
AlN 308.3[42] 130.8[42] 0.179[42] 3.26[43] 6.72[44] −2.71[44]
ZnO 112.2[45] 42.2[45] 0.336[45] 5.53[45] 12.3[46] −5.12[46]
BaTiO3 112[47] 43[48] 0.35[49] 5.4[47] 140[47] −60[47]
PbTiO3 213.7[50] 84.3[50] 0.26[50] 7.52[51] 79.1[52] −23.1[52]
SiO2 72.52[53] 30.97[53] 0.166[53] 2.204[53] d11 = 2.3[54] d14 = −0.67[54]
PVDF 2[55] 0.752[55] 0.33[55] 1.8[55] −22[56] 23[55]
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w, and thickness h. The mass change of the beam in bending 
mode due to adsorption of virus particles is obtained by
m
k



















Figure  7a shows an example of the fabrication process 
method for a microelectromechanical mass-sensor based 
on the cantilever beam, actuated using a piezoelectric ZnO 
thin film.[62] The beam stack consists of Si/SiO2/Pt/ZnO/
Pt layers. First, Si wafers are cleaned and wafers are loaded 
in a thermal oxidation furnace for thermal SiO2 growth. 
The SiO2 layer is then patterned, and the Si windows are 
opened. The bottom Pt electrode (Pt-B) is coated, and ZnO 
is deposited. After that, the top Pt electrode (Pt-T) is coated, 
and the Si wafer is etched. Finally, the device structure 
is released, and the top window is opened. A selectively 
mass-loading ZnO layer is deposited. Figure  7b,c shows 
the top view of bare and mass-deposited cantilever beams, 
respectively.
2.1. Human Papilloma Virus: Group I
As the third most commonly occurring cancer in women, cer-
vical cancer can be caused by human papillomavirus (HPV). 
HPV is a deoxyribonucleic acid (DNA) virus belonging to the 
Papillomaviridae family and is one of the most easily sexually 
transmittable viruses globally since millions of people have 
been infected with HPV at some point in their lives. It should 
also be noted that HPV viruses may have no effects in most 
people; however, some types can cause health problems such 
as genital warts or cancer. In February 2019, an HPV vaccine 
was introduced in 92 countries as part of a national vaccina-
tion program, but remains important to solve such problems 
as unstable vaccine supply, high delivery cost, and low seed 
rate still prevail. Given the prevalence of this virus, researchers 
focus on developing effective monitoring methods for high-risk 
HPV communities.[63]
To identify the HPV in recurrent and original pathological 
biopsy samples, Fu et  al.[64] used AT-cut 10  MHz piezoelectric 
quartz crystal and fabricated piezoelectric genesensors. A 
method for the rapid detection of HPV using piezoelectric gen-
esensors was developed, and the detection effectiveness was 
compared with those of conventional PCR-dot blot hybridiza-
tions. The researchers assumed that the results obtained from 
the piezoelectric genesensors and PCR-dot blot were almost 
identical. Dell'Atti et al.[65] combined DNA piezoelectric sensors 
with PCR to create label-free DNA piezoelectric biosensors for 
detecting HPV from human cervical scraping specimens. They 
optimized the piezoelectric sensors with synthetic oligonucle-
otides and performed the tests on cervical scraping samples 
after PCR amplification. Reproducibility was expressed as the 
average coefficient of variation (CV%) for three samples, and a 
good reproducibility of approximately 10% was obtained. Chen 
et al.[66] designed an adjustable, stainless-steel, metal-clamping, 
piezoelectric sensor. They detected the hybridization of HPV 
PCR products and discussed the effect of temperature change 
on the frequency baseline stability. Their results showed that 
the change in frequency amplitude can reach Δf = 55 ± 7.4 Hz 
when the target product of 40 μL in an ice bath was added to 
110 μL of the buffer. Prakrankamanant et  al. combined the 
loop-mediated isothermal amplification (LAMP) technique with 
QCM for real-time detection of high-risk HPV DNA type 58 
(HPV-58), most commonly found in Asian women.[67] AT-cut 
9 MHz piezoelectric quartz crystals with polished Au electrode 
coatings on both sides were used. The effect of the changes 
in temperature and viscosity on the QCM sensor during the 
PCR process was addressed, and the sensitivity was further 
increased. The system could detect HPV-58 at 100 copies 
with Δf  = 34 ± 3.6  Hz. However, the analyte in this method 
was in contact with the reusable sensor surface, which could 
lead to the risk of carryover contamination. It has also been 
reported that the diagnostic specificity is low (90.5%) because 
Figure 6. Photograph of quartz crystals and measured Q values; measurements were carried out in air and in phosphate-buffered saline. Reproduced 
with permission.[60] Copyright 2007, Elsevier.
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of disagreement in results of HPV-58 positive by LAMP-QCM 
but negative by the conventional LAMP technique. So, further 
research and development are required.
2.2. Vaccinia Virus: Group I
Vaccinia virus is the prototype virus of the orthopoxvirus genus 
in the family Poxviridae and is found in multiple infectious 
forms including intracellular mature virus.[68] QCM technology 
was applied for real-time airborne detection and quick detec-
tion of vaccinia virus.[69,70] Kleo et  al.[69] established a unique 
detection system for the identification of vaccinia virus by 
combining QCM detection techniques and PCR amplification. 
To ensure that the PCR products can be detected directly by the 
QCM-based detection system, a pretreatment via denaturation 
(95 °C) and fast cooling down with precooled buffer (4 °C) was 
performed. The required analytical time for the new system 
was 15 min, which is less than those of the traditional methods. 
Lee et  al.[70] developed a method for the real-time detection of 
airborne vaccinia virus using an integrated QCM technique. 
The capture rate varied linearly with the concentration of the 
initial virus suspensions (8.5 × 108 to 8.5 × 1010 particles mL−1) 
at flow rates of 2.0 and 1.1 L min−1. The research demonstrated 
the potential of QCM on the detection of nanoscale biological 
entities in air.
Figure 7. Microcantilever beam in piezoelectric biosensor. a) Fabrication process of a piezoelectric cantilever; b) top view of the cantilever; and 
c) cantilever coated with mass-loading zinc oxide (ZnO) layer. a–c) Reproduced with permission.[62] Copyright 2019, IEEE.
Adv. Mater. 2020, 2005448
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2.3. Dengue Virus: Group IV
As a mosquito-borne viral disease, dengue fever (DENV) has 
numerous patients.[71] Although it is of major public health 
concern in urban and semiurban areas, leading to thousands 
of deaths per year, the current detection procedures are cum-
bersome and time-consuming.[72,73] Wu et  al.[74] developed a 
dengue fever piezoelectric immunochip. They used a 10 MHz 
QCM consisting of an 8 mm AT quartz wafer placed between 
Au electrodes to detect dengue envelop protein (E protein) 
and nonstructural protein 1 (NS-1 protein) in a viremia phase 
patient serum, and obtained a detection limit for the phosphate 
buffered saline (PBS) diluted samples. The immunochip failed 
to quantify dengue virus antigens in 1/1000 untreated samples, 
so they used the cibacron blue 3GA gel–heat denature (CB–HD) 
method and succeeded in reducing the dilution from thousand-
fold to hundredfold. They found that the CB–HD method was 
the most effective sample pretreatment technique, demon-
strating detection limits as low as 1.727 μg mL−1 for E protein 
and 0.740 μg mL−1 for NS-1 protein. Tai et al.[75] coated the QCM 
with molecularly imprinted polymers (MIP) specific to the NS-1 
protein of flavivirus including dengue virus serotypes. The 
advantages of this MIP-QCM to detect dengue virus were high 
sensitivity (1–10 ng mL−1), short operation time (20–30 min per 
sample), and easy interpretation.
Chen et al.[76] established a circulating-flow QCM biosensing 
method. Au nanoparticles (AuNPs) were integrated into AT-cut 
9  MHz piezoelectric quartz crystal. The specific oligonucleo-
tide-functionalized AuNP probes were used as both detection 
amplifiers and verifiers in this method. The temperature of the 
QCM system was maintained at 30 °C. The detection limit of 
the QCM instrument in liquid was 1 Hz, and the Δf = 1 Hz cor-
responded to Δm  = 0.391  ng. In the nanoparticle application, 
this method was able to detect dengue virus cDNA in clinical 
blood samples at two plaque forming unit (PFU) per milli-
liter. A linear correlation (R2  = 0.987) of the detection signal, 
i.e., Δf versus virus titration, was found over a concentration 
range from 2 to 2 × 106 PFU mL−1. Furthermore, the technique 
was label-free and highly sensitive. Concentrations as low 
as 2 PFU mL−1 of DENV could be detected, compared to the 
1–50 PFU mL−1 detection limit for fluorescent (i.e., not label-
free) real-time PCR.
The commercialization of dengue virus sensors remains far 
from imminent due to remaining issues with clinical samples 
and the piezoelectric sensor itself.[77] Pirich et al.[78] proposed the 
functionalization of commercial piezoelectric sensors with cel-
lulose nanocrystal (CN) thin films to anchor monoclonal immu-
noglobulin against NS-1 dengue antigen. Figure 8a shows the 
atomic force microscopy (AFM) topography image of CN, while 
Figure 8b–f shows the AFM topography images of piezoelectric 
sensor surfaces. Since the Au surface (Figure 8b) is known to 
hinder stable CN adsorption, a preliminary step was performed, 
coating the sensor with polyethylenimine (PEI) (see Figure 8c). 
The CN film was then anchored as shown in Figure 8d. The CN 
film was activated by an injection of 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide/N-hydroxysuccinimide (i.e., EDC/NHS) 
solution as shown in Figure  8e, and a monoclonal immuno-
globulin G (IgGNS1) solution was injected for immobilization 
(Figure 8f). QCM was used to assess both antigen recognition 
and the frequency change Δf of the immunochips during the 
assembly process. Interaction analyses of the activation of the 
CN thin films were also performed by a QCM with energy-dis-
sipation monitoring (QCM-D). The system was found capable 
of detecting IgGNS1 in the range of 0.01–10  μg mL−1 by both 
QCM and QCM-D. The detection limits were 0.32 μg mL−1 for 
QCM and 0.1  μg mL−1 for QCM-D. Figure  8g shows the fre-
quency change Δf over time during NS-1 detection using the 
QCM-D. QCM and QCM-D apparatuses can be employed in 
NS-1 recognition and show potential for more sensitive, faster, 
and/or less expensive diagnostic assays for dengue (Table 3).
2.4. Ebola Virus: Group V
Ebola virus was first identified in 1976, and thousands of 
people, including numerous health care workers, have died due 
to this disease.[79] Ebola virus disease (EVD), formerly known as 
Ebola hemorrhagic fever, is a severe, often fatal illness affecting 
humans and other primates. The virus is transmitted to people 
from wild animals (such as fruit bats, porcupines, and non-
human primates) and then spreads in the human population 
through direct contact with the blood, secretions, organs, or 
other bodily fluids of infected people, and with surfaces and 
materials (e.g., bedding and clothing) contaminated with these 
fluids. The average EVD case fatality rate is around 50%. Case 
fatality rates varied from 25% to 90% in past outbreaks.[80] 
Rapid POC care detection of the Ebola virus could enable early 
quarantine and help halt pandemics.
Baca et  al.[81] fabricated a surface acoustic wave (SAW) 
sensor and proposed a label-free sensing system for the rapid 
detection of Ebola antigens at the POC without the need for 
added reagents, sample processing, or specialized personnel. 
The sensor chips were prepared using lithium tantalate 
(LiTaO3) wafers with inter-digital transducers (IDTs). The 
piezoelectric substrate propagated horizontally polarized sur-
face shear waves induced by application of an AC voltage (sev-
eral hundred millivolts to several volts) to the IDTs at a high 
frequency between 80 and 400  MHz. Molecular interactions 
between virus and antibody emitted an acoustic wave leading 
to a change in the input frequency. That is, detection of Ebola 
virus resulted in a frequency increase, with phase shift values 
ranging from 0.20 ± 0.04° to 4.46 ± 0.86°. They observed a 
log–linear sensor response for Ebola viral particles, with a 
detection limit of 1.9 × 104 PFU mL−1. They predicted that 
the SAW sensor would greatly improve testing sensitivity for 
infectious Ebola virus. The SAW sensor phase shift response 
seems to perform well for an infectious Ebola sample. How-
ever, the characteristics of acoustic waves depend on the 
temperature, so attention must be paid to the measurement 
environment.
2.5. Influenza A Virus: Group V
New viruses are causing outbreaks, and old viruses grow 
stronger every day, influenza virus (types A, B, C, and D) 
among them. Hence, current sensing methods require contin-
uous upgrading to manage the numerous growing challenges 
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for virus diagnosis.[57] Influenza A virus, a general type, has 
high mutagenicity and infectivity and is the most prevalent and 
severe infection. Type A exhibits a route of transmission from 
person to person as well as from animal (bird, pig, horse, etc.) 
to person. Influenza B virus has a slower rate of change than 
type A and has relatively mild symptoms. Although infectivity 
is high, the infection route is from person to person, and it is 
less likely than type A to cause a high fever. Once influenza 
C viral immunity has been acquired, that immunity persists 
for life. Reinfection is reminiscent of the common cold. The 
influenza D is suggested to be one of the viruses responsible 
for bovine respiratory disease complex.
The influenza A virus is often discussed as a worldwide influ-
enza epidemic. As the shape of the virus continues to evolve, 
acquired immunity performance drops, and strain prediction 
becomes more difficult for vaccine producers. Figure 9 shows 
changes in the number of people infected with the influenza 
A virus in Japan over the past 10 years. According to the World 
Health Organization, the A(H1N1)pdm09 strain, which is a new 
version of the H1N1 (commonly known as the Spanish flu), was 
responsible for the 2009 influenza pandemic. A part of H3 is 
known as the Hong Kong Cold. Since current methods for the 
diagnosis of influenza require specialized laboratory facilities 
and highly trained personnel and, in the case of viral culture, 
can take up to 14 days to obtain a definitive result, a QCM-based 
sensor has been developed for the rapid detection of both influ-
enza A and B viruses in laboratory-cultured preparations and 
clinical samples.[82]
Jiang et  al.[83] designed and fabricated Love wave SAW sen-
sors with SiO2-coated lithium niobate (LiNbO3) piezoelectric 
wafers for the detection of influenza A viral antigen. Figure 10a 
Figure 8. Piezoelectric immunochip coated with bacterial cellulose nanocrystals (CNs) for dengue virus detection. a) Atomic force microscopy (AFM) 
topography image of CN; b–d) AFM topography images of piezoelectric sensor surfaces coated with: b) Au, c) polyethylenimine (PEI) film, d) CN film; 
e,f) the interfaces obtained after N-hydroxysuccinimide (HNS) activation (e) and monoclonal immunoglobulin G (IgGNS1) immobilization (f); and 
g) frequency shift profile during NS1 antigen (in blood serum diluted tenfold in phosphate buffered saline) recognition by the IgGNS1 using a quartz 
crystal microbalance with energy-dissipation monitoring (QCM-D). Before test recognizing the NS1 antigens, unspecific regions are blocked by injection 
of albumin solution. a–g) Reproduced with permission.[78] Copyright 2017, Elsevier.
Table 3. Reported limits of detection for dengue virus.
Target Detection limit Ref.
E protein 1.727 μg mL−1 [74]
NS-1 0.740 μg mL−1 [74]
NS-1 1–10 ng mL−1 [75]
cDNA 2 PFU mL−1 [76]
NS-1 0.1 μg mL−1 [78]
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shows a schematic of the preparation of the active surface for 
the SAW sensors. Figure 10b,c shows the test setup. Figure 10d 
shows the phase changes measured for the SAW sensor 
exposed to PBS powder and H1N1 HA antigen solutions. A 
detection limit as low as 1 ng mL−1 was obtained for influenza 
A H1N1 HA antigen at room temperature. Erofeev et  al.[84] 
described label-free rapid detection of influenza A virus using 
Ag-coated lead zirconate titanate (PZT) piezoelectric disks of 
Figure 9. Number of specimens positive for influenza A in Japan in the period 2011–2019.
Figure 10. Surface acoustic wave (SAW) sensor for influenza A virus detection. a) Preparation of bioactive surfaces for SAW sensors; b) photograph of 
a SAW sensor mounted onto a fixture with low-loss microwave probes; c) photomicroscopy image of the microwave probes in contact with the elec-
trodes; and d) phase change versus time for a SAW sensor exposed to H1N1 HA antigen solutions of various concentrations and phosphate-buffered 
saline (PBS). a–d) Reproduced with permission.[83] Copyright 2015, Elsevier.
Adv. Mater. 2020, 2005448
www.advmat.dewww.advancedsciencenews.com
2005448 (11 of 24) © 2020 The Authors. Advanced Materials published by Wiley-VCH GmbH
100  μm thickness. The disks, modified with synthetic sialyl-
glycopolymers based on a polymer matrix, which biospecifically 
bind the haemagglutinin proteins on the influenza viruses, 
were inserted in a flowing virus suspension. Figure 11a–f shows 
the fabrication process of the PZT disk sensor. Label-free detec-
tion of the virus was achieved by monitoring the shift in disk 
radial mode resonance frequency. Figure  11g presents differ-
ences between the resonance frequency shifts for influenza A 
virus concentrations of 0, 105, 106, and 107 virions mL−1. Label-
free detection of influenza A viruses at concentrations below 
105 virions mL−1 was demonstrated. It was also shown that 
frequency shift is proportional to the surface stress induced 
by virus adsorption (Figure  11h). Furthermore, the sensitivity 
was found to be inversely proportional to the thickness of the 
resonator. Hence, by using a thinner PZT substrate, the sensi-
tivity can easily be increased several-fold. It is expected that this 
PZT disk sensor method for influenza A virus detection can be 
extended to home application.
2.6. Human Immunodeficiency Virus: Group VI
HIV was first documented as a dangerous blood-borne pathogen 
in the early 1980s, and HIV detection methods have gradually 
improved in terms of both sensitivity and specificity.[85] HIV is 
a lentivirus that leads to acquired immunodeficiency syndrome 
(AIDS), and with increasing awareness of AIDS emerging as 
a global public health threat, a wide range of biosensors have 
been developed for early diagnosis of HIV infections.[86]
Properties of piezoelectric acoustic sensors using AT-cut 
20  MHz quartz wafer have been evaluated for HIV-1 
(nonspecific) versus HIV-2 (specific) antibody–antigen 
Figure 11. Disk sensor for influenza A virus detection. a–f) Fabrication process: a) Ag-coated lead zirconate titanate (PZT) plate of 100 μm thickness; 
b) plate after incubation in 98% nitric acid solution; c) Au-coated plate (coating thickness: 50 nm); d,e) 4 mm disk cut with chopped carbide grade from 
laminated Au-coated plate; f) holder that clamps disk in the center. g) Resonance frequency shift as a function of time for different virus concentrations; 
and h) frequency shift as a function of surface stress due to virus concentrations. a–h) Reproduced under the terms of the CC-BY Creative Commons 
Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0).[84] Copyright 2019, The Authors, published by The Royal Society.
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interactions.[87] It has been shown that the introduced sensor 
is effective in detecting and distinguishing HIV-2 from HIV-1 
antibodies with good selectivity. Lu et  al.[88] fabricated a MIP-
coated QCM biomimetic sensor for the detection of HIV-1-re-
lated protein (glycoprotein 41(gp-41)). It was found that the MIP 
film not only exhibited a strong affinity for the template pep-
tide, but also could specifically bind the corresponding HIV-1 
protein. The detection limit was 2 ng mL−1.
PCR and antibody capture by an enzyme-linked immuno-
sorbent assay for HIV-1 and HIV-2 are time-consuming and 
require sophisticated equipment that is not compatible with 
emergency POC requirements. Bisoffi et al.[89] developed a pro-
totype biosensor based on functionalized piezoelectric materials 
with specific antibodies against HIV-1 and HIV-2. They prepared 
a new generation of biosensor chips with altered dimensions 
and an increased area occupied by the IDTs as wafers. They 
employed lithographic deposition and patterning of the IDT and 
the SiO2 waveguide layers, followed by cutting of the final format 
of the chips. While most other technologies require 30–60 min 
to detect a potential infection, the developed biosensor detected 
the presence of virus within 5 min, including the distinction 
between HIV-1 and HIV-2. Hence, this prototype biosensor may 
have the potential to be developed into a device for use in appli-
cations that require rapid and reliable testing for potential HIV 
infections in blood donors. HIV-1 antigens were detected by the 
QCM using AuNPs as a signal enhancer.[90] The QCM sensor, 
consisting of cavity resonators constructed over a piezoelectric 
substrate, would accumulate electric charges in response to the 
applied stress. Four AuNPs of different sizes were prepared (see 
Figure 12a). Figure 12b shows the transmission electron micro-
scopy (TEM) image of the resulting AuNPs, with average dia-
meters of 21, 30, 63, and 126 nm. Figure 12c shows the effect of 
NP size on the detection signal. The target HIV-1 antigen con-
centration was 1 ng mL−1. Streptavidin–Au with a size of 30 nm 
yielded the strongest signal. That is, using streptavidin–Au as an 
amplifier, a limit of detection of 1 ng mL−1 was reached.
2.7. Hepatitis B Virus: Group VII
Hepatitis B virus (HBV) infection is one of the most common 
health problems in the world.[91] Although billions of people 
suffer from HBV, effective medicine and treatment are unfor-
tunately not found to cure chronic HBV infection. Therefore, 
detecting and monitoring HBV during the early stages of 
infection is of great importance. Xu et al.[92] developed a piezo-
electric diaphragm-based immunoassay chip using microfabri-
cation technology to detect anti-HBV and anti-alpha-fetoprotein 
(AFP). Firstly, a thin TiO2/Pt film was sputter-deposited on 
the top side of a Si-on-insulator wafer as the bottom electrode. 
A thin PZT film was then deposited by a sol–gel deposition 
method, and the PZT film was wet-etched. A Si3N4 layer was 
deposited, and the Ti/Pt top electrode was sputtered. Figure 13 
shows optical and scanning electron microscopy (SEM) images 
of the fabricated sensor chip. The chip consists of eight indi-
vidual sensors in a sandwich structure with a circular top elec-
trode, a PZT diaphragm, and a bottom electrode, as shown 
in Figure 13a. Figure  13b presents the back-side of the sensor 
array. Figure 13c shows a top-view SEM image of one reaction 
chamber, while Figure  13d shows a cross-sectional SEM view 
of the same. Figure  13e shows the processing time effect on 
the frequency change due to the binding activity of the antigen. 
For example, sensors 2 and 3 were kept in air for 30  min 
before applying antigen solution, and the frequency was meas-
ured after the interaction time. Sensors 1 to 4 successfully 
captured the antibodies, as shown in Figure  13f. A detection 
limit of 0.1  ng mL−1 was obtained from the frequency shift-
based calibration curves. The fabricated sensor chip could be 
used to simultaneously detect multiple analytes. Giamblanco 
et al.[93] described a single-step, label-free method to selectively 
detect the HBV genome. Au-coated QCM crystals consisting 
of a Au layer with a chromium adhesion layer were used, and 
QCM-D measurement was carried out. At a probe density of 
4.0 × 1012 molecules cm−2, a sensitivity of tens of ng cm−2 could 
be obtained for the HBV target without using any amplification 
steps or labeling method.
To further improve detection performance, piezoelectric 
plate technology should be combined with other technologies 
such as sensitive membranes, microfluidics, and nanoparticles. 
By using a (Pb(Mg1/3Nb2/3)O3)0.65(PbTiO3)0.35 (i.e., PMN–PT) 
piezoelectric plate sensor coated with probe DNA, in situ 
detection of HBV double mutation (HBVDM) in urine has 
been previously discussed.[94] The PMN–PT layer coated with 
Figure 12. Quartz crystal microbalance (QCM) for human immunodeficiency virus (HIV)-1 detection. a) Au nanoparticle (AuNP) solutions; b) TEM 
images of Au particles; and c) frequency changes upon streptavidin–Au immobilization. The error bars represent the standard deviations of four rep-
licates. a–c) Reproduced with permission.[90] Copyright 2016, Elsevier.
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Au electrodes on the two major surfaces and encapsulated by 
thin electrical insulation is shown in Figure 14a. The binding 
of the target DNA from the biological fluid sample to the probe 
DNA on the piezoelectric plate sensor surface shifted the 
sensor length-extension mode (Figure 14b) and width-extension 
mode (Figure  14c) resonance frequencies. Figure  14d shows 
an optical microscopy image of the sensor. This piezoelectric 
plate sensor was shown to detect HBVDM with an analytical 
sensitivity of 60 copies mL−1. After the test, the sensor was 
examined using a fluorescence microscope, and the obtained 
fluorescence images from detection at mutation concentrations 
of 100 × 10−21 m (10−16  mol m−3), 1 × 10−18 m (10−15  mol m−3), 
10 × 10−18 m, and 100 × 10−18 m are shown in Figure  14e–h, 
respectively. The blue and orange spots represent the mutation 
fluorescent reporter microspheres and wild type fluorescent 
reporter microspheres. The PMN–PT piezoelectric plate sensor 
was also able to detect double-stranded HBVDM and K-ras 
point mutation with a detection efficiency of 70% or better at 
concentrations as low as 10−19 m (10−16 mol m−3) against single-
stranded mutation detection at the same concentrations.[95]
Figure 13. Micro-piezoelectric immunoassay chip for hepatitis B virus detection. a,b) Optical image of front-side (a) and reverse-side (b) views of a 
piezoelectric sensor array. c,d) Top (c) and cross-sectional (d) SEM image views of a reaction chamber. e) Measured frequency shift due to the binding 
activity of the immobilized antigen. The error bars represent the standard deviations of three replicates. f) Fluorescence image of the piezoelectric 
sensor array after capturing the specific antibodies. a–f) Reproduced with permission.[92] Copyright 2011, Elsevier.
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3. Magnetostrictive Biosensors
The magnetostrictive microcantilever (MSMC) has been inves-
tigated as a remote biosensor platform[96] that works well in 
either air or liquid. The principle of the biosensor is based on 
the resonance frequency change Δf with the mechanical load 
change as described in Section  2. A schematic illustration of 
the operation principle of the MSMC is shown in Figure  15. 
Probe antibodies are fixed on the upper biosensor chip as 
shown in Figure  15a. Due to the magnetostrictive effect, the 
Figure 14. a) Schematic of a piezoelectric plate sensor for Hepatitis B virus double mutation (HBVDM) detection; b) the first length-extension mode 
and c) width-extension mode vibration of the piezoelectric plate sensor, with the shaded bars indicating the initial position of the piezoelectric plate 
sensor and the dashed shapes illustrating the extended positions. d) Top-view optical microscopy image and e–h) fluorescence images of the sensor 
obtained after fluorescent reporter microsphere detection that followed the mutation detection in a mixture of mutant with 250 times more wild type 
at mutation concentrations of: e) 100 × 10−21 m, f) 1 × 10−18 m, g) 10 × 10−18 m, and h) 100 × 10−18 m. a–h) Reproduced with permission.[94] Copyright 
2015, The Royal Society of Chemistry.
Figure 15. Basic concept of virus detection using magnetostrictive material. a) Operation principle of a magnetostrictive biosensor; b) schematic of 
magnetostrictive microcantilever (MSMC), driving coil and pick-up coil; and c) schematic of amplitude to frequency during detection.
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application of an AC magnetic field using a driving coil as 
shown in Figure 15b induces an oscillation of the MSMC. The 
attachment of a mass load Δm such as an antigen to the sensor 
surface with probe antibodies lowers the resonance frequency 
(see Figure  15c). The oscillation results in an emission of a 
magnetic flux, and changes in the amplitude and phase signal 
of the oscillation lead to a magnetic flux change that can be 
detected using a pick-up coil (Figure 15b). Metglas amorphous 
alloy,[97–99] Fe–Co alloy,[32,100,101] and cobalt ferrite (CoFe2O4) 
ceramics[102–104] are widespread materials for magnetostrictive 
applications. Table  4 lists the Young’s modulus E, Poisson’s 
ratio ν, mass density ρ, piezomagnetic constant d33m , and mag-
netostriction λ values for these materials.
MSMC performance is characterized by the mass sensitivity 
and the Q value. For MSMCs made of a commercial magne-
tostrictive Metglas alloy, for example, the Q value can reach 
more than 500 when operated in air and 30 when operated in 
water.[96] In addition, the Q value of Metglas under multihar-
monic resonance modes can be as high as 1000 in air and over 
100 in water.[105] On the other hand, magnetoelastic particles 
composed of an amorphous iron–boron binary alloy exhibit a Q 
value of 656 in air.[106] Compared to piezoelectric microcantile-
vers, MSMCs have simple configurations.
For a thin sensor vibrating in its basal plane, the funda-












If the mass increase is small compared to the initial mass ρlwh 
of the sensor, then the mass change of the plate in longitudinal 
mode due to adsorption of virus particles, according to the 




ρ∆ = − ∆2
0
 (6)
Equation (6) shows that increasing mass on the sensor surface 
produces a linear reduction in resonance frequency. If the mass 
of a single virus is known in advance, the number or type of the 
virus can be identified from the change in frequency.
From Equation (6), it can be seen that the sensitivity (Δf/Δm) 
is proportional to the resonance frequency f0 and inversely 
proportional to the magnetostrictive biosensor mass ρlwh. 
This feature does not apply to the piezoelectric biosensors (see 
Equation  (1) or (4)). Smaller magnetostrictive biosensors have 
higher f0 and lower ρlwh, leading to higher sensitivity. However, 
as the biosensor size decreases, the amplitude of the detected 
signal decreases and the signal-to-noise ratio decreases, making 
signal processing harder.[108] Theoretical results showed that the 
sensitivity depends on the mass distribution[109] and is propor-
tional to the square of mode shape[110] of the sensor.
MSMC shows numerous advantages: 1) its actuation and 
sensing unit is wirelessly controlled; 2) its fabrication process is 
relatively easy; and 3) it works well in liquids.[31]
3.1. Bacterial Spore
The magnetostrictive platform has a unique advantage over 
conventional sensor platforms in that measurement is wireless 
and remote. This advantage is achieved by using the driving 
and pick-up coils, as shown in Figure 15b.
A biosensor for the detection of bacterial spores has 
already been developed. Metglas 2826  MB alloy was used as 
the sensor platform. The composition is Fe40Ni38Mo4B18, with 
a theoretical saturation magnetostriction value of 11  ppm. 
The detection targets were yeast cell[96] and acid phos-
phatase.[111,112] This sensor was also used to detect Salmonella 
typhimurium bacteria. Guntupalli et  al.[113] constructed a bio-
sensor immobilizing a polyclonal antibody onto the surface 
of Metglas 2826  MB alloy, in order to detect S. typhimurium 
in air. Because the increased mass of S. typhimurium was 
very small compared to the initial mass of the biosensor, they 
determined the mass change due to the bacteria binding from 
Equation (6). They compared the density of bacteria cells cal-
culated from Equation  (6) and the density of bacteria cells 
measured by SEM, and obtained good agreement between the 
different methods. Detection limit of 5 × 103 colony forming 
unit (CFU) mL−1 was obtained for 15  μm thick sensor with 
size of 2 mm × 0.4 mm. Fu et al.[114] demonstrated the detec-
tion of S. typhimurium bacteria in water using the Cu/Met-
glas bilayer.
Johnson et  al.[106] fabricated magnetoelastic particles com-
posed of an amorphous iron–boron binary alloy Fe79B21 by 
sputtering onto a chromium and Au-coated Si wafer, and 
explored functionality in the detection of Bacillus anthracis 
spores. They obtained a correlation between the actual 
number of spores bounded to the biosensor and the calcu-
lated mass increase based on the resonance frequency shift 
from the experiments. Li et al.[115] performed the in situ detec-
tion of B. anthracis spores in water in a real-time manner 
using a Cu/Metglas bilayer. Li and Cheng[105] then showed 
that the sensitivity of the biosensor is strongly dependent on 
the location of the mass load. The detection of Escherichia 
coli[116] and B. Anthracis spores[117] in water has been reported 
using the Cu/Metglas bilayer. Biosensors for in situ detec-
tion of pathogenic bacteria in liquid has been developed 
using magnetostrictive Metglas particles.[39,118] S. typhimu-
rium, Listeria monocytogenes, E. coli, and Staphylococcus aureus 
were characterized. In addition, Metglas 2826  MB alloy bio-
sensors specific to S. typhimurium have been prepared by 
immobilizing antibody or phage as biorecognition elements 
onto the sensor.[119] It was demonstrated that bacteriophage 
immobilized sensors have much better thermal stability 
than antibody immobilized sensors. Table 5 summarizes the 
detection limit of the Metglas sensor as applied to various 
targets.[113–120]
Table 4. Engineering constants of magnetostrictive materials.
E [GPa] ν ρ [g cm−3] 33md  [nm A−1] λ [ppm]
Metglas 100[97] 0.33[98] 7.9[97] 50.3[99] 11[97]
Fe–Co 182[100] 0.3[100] 8.4[32] 0.125[101] 80–140[32]
CoFe2O4 154[102] 0.37[102] 5.29[103] −1.88[102] −273[104]
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3.2. Protein
The Metglas 2826 MB biosensor for the detection of glucose[108] 
has been developed. Recently, Sang et  al.[121] designed small, 
cost-effective, stable Metglas 2826  MB biosensor to detect 
human serum albumin (HSA) rapidly and specifically, with 
a detection limit as low as 0.039  μg mL−1 (Table  5). Figure  16 
shows the magnetostrictive sensor and sensing system. Wang 
et  al.[122] developed the Metglas nano-biosensor for detecting 
carcinoembryonic antigen (CEA) by biological modification on 
the surface of the sensor platform. The nano-biosensor had a 
linear response to the logarithmic CEA concentrations ranging 
from 2 pg mL−1 to 6.25  ng mL−1, with a detection limit of 
1 pg mL−1 (Table 5) and a sensitivity of 105.05 Hz mL ng−1.
3.3. Classical Swine Fever: Group IV
Classical swine fever, which is caused by the swine fever 
virus (CSFV), is a serious, economically damaging disease of 
swine,[123] and CSFV detection has been extensively investigated 
in connection with economic damage to the pig industry. A 
magnetostrictive sensing system for the detection of CSFV has 
been published.[124] In that study, the magnetostrictive sensor 
platform was composed of Metglas 2826 alloy (Fe40Ni40P14B6). 
The experimental data showed a sensitivity of approximately 
95  Hz mL μg−1 for the CSFV detection sensor, with a detec-
tion limit of 0.6  μg mL−1. A magnetostrictive sensor immobi-
lized with E2 glycoprotein was developed to detect CSFV E2 
antibodies.[125] Figure  17a–c shows a SEM image of the sen-
sor’s Au surface without and with functionalization, as well 
as the energy-dispersive X-ray spectroscopy (EDS) spectra for 
elemental analysis of the sensor surface before and after the 
immobilization of CSFV E2. It was found that the Au content 
decreases after CSFV E2 immobilization. On the other hand, 
E2 contains large quantities of carbon and oxygen due to the 
nature of the envelope glycoprotein, so it is clear that carbon 
and oxygen accumulation also increased dramatically after 
CSFV E2 immobilization. From Figure  17d, it was observed 
that the resonance frequency shift increases with increasing 
CSFV E2 antibody concentration. The sensor showed a linear 
response to the logarithm of CSFV E2 antibody concentration, 
with a sensitivity of 56.2 Hz mL μg−1 and a detection limit of 
2.466  ng mL−1. This sensor constituted a low cost, high sen-
sitivity, wireless method for the selective detection of CSFV 
E2 antibodies. This CSFV E2 study not only proposed a new 
method for antibody detection but also demonstrated the poten-
tial utility of the method in real-life diagnosis.
4. Future Outlook
The research outcomes reported above have demonstrated the 
potential and benefits of piezoelectric and magnetostrictive 
materials in detecting specific viruses. Table 6 summarizes the 
various materials and methods. Near future work should further 
improve the accuracy and efficiency, reduce the tester size and 
weight, and enhance the wearability of virus sensors through 
the bespoke design and fabrication of multifunctional piezo-
electric and magnetostrictive materials. For example, lamination 
Table 5. Reported limits of detection for various harmful substances.
Target Detection limit Ref.
S. typhimurium 5 × 103 CFU mL−1 [113]
B. anthracis in water 105 CFU mL−1 [115]
E. coli in water 105 CFU mL−1 [116]
B. anthracis in water 104 spores mL−1 [117]
Pathogens in water 100 CFU mL−1 [118]
Octachlorostyrene 2.8 × 10−9 m [120]
Human serum albumin 0.039 μg mL−1 [121]
Carcinoembryonic antigen 1 pg mL−1 [122]
Figure 16. Magnetostrictive sensor for human serum albumin detection. a) Two test slots for magnetostrictive biosensor chips including reference 
and sensing chips; b) components and assembly process of magnetostrictive biosensor; and c) components of the sensing system. a–c) Reproduced 
with permission.[121] Copyright 2019, Elsevier.
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of piezoelectric and magnetostrictive layers[126] or dispersions of 
magnetoelectric (ME) nanoparticles[127] (see Figure 18a) might be 
one area of interest. Figure 18b shows a TEM of ME composite 
made of the magnetostrictive core CoFe2O4 and piezoelectric 
shell BaTiO3. To achieve a design optimized for sensor perfor-
mance and benefits, parametric studies need to be conducted 
through theoretical investigation[128,129] including multiphysics 
and multiscale numerical simulation.[130–132] Improving mode-
ling accuracy could remarkably increase the efficiency of the 
structural optimization of computational interactions between 
mechanical and electromagnetic fields, thereby reducing the 
time and cost of manufacturing and tooling in experiments. At 
the same time, such enhancement would also help to determine 
the microscale/nanoscale mechanisms impacting both mechan-
ical and electromagnetic behavior of the functional piezoelectric 
and magnetostrictive materials.
Here, some key guidelines are summarized for improving 
the performance of the piezoelectric and magnetostrictive 
biosensors:
1. It is desired to develop piezoelectric and magnetostrictive sen-
sors that can detect the viruses from changes of the output volt-
age instead of the resonance frequency change, as mentioned 
in the Introduction. For the piezoelectric sensors, both driving 
and sensing electrodes are needed.[47] The benefit of this detec-
tion method is that it does not require fast Fourier transform 
(FFT) or discrete Fourier transform (DFT) analysis and will 
shorten the detection time. In order to increase the sensitivity 
(e.g., output voltage change with respect to the mass change), it 
is necessary to investigate and identify the optimum materials 
and structures and vibration mode by numerical simulation.
2. As mentioned earlier, the sensitivity varies depending on the 
distribution[109] and location[105] of the virus mass. Therefore, 
it is recommended to simulate the effects of the distribution 
and location of the mass on the sensitivity of the biosensor 
subjected to vibration. At this time, it is important to under-
stand the locations of the stress concentration and strain con-
centration of the biosensors. This knowledge will provide an 
effective route to the design and optimization of the biosensor.
Figure 17. Magnetostrictive sensor for classical swine fever virus (CSFV) detection. a) SEM image of the Au-coated sensor surface; b) SEM image of 
the biosensor surface after CSFV E2 immobilization; and c) EDS spectrum of the biosensor surface before and after the CSFV E2 immobilization. After 
CSFV E2 immobilization, it is clear that the Au content is reduced while the carbon and oxygen accumulations are dramatically increased. E2 contains 
large amounts of carbon and oxygen due to the nature of the envelope glycoprotein. d) Frequency shift as a function of time for phosphate buffered 
saline (PBS) and different anti-CSFV E2 antibody concentrations. a–c) Reproduced with permission.[125] Copyright 2017, Springer Nature. d) Reproduced 
with permission.[124] Copyright 2016, Elsevier.
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3. By designing a composite biosensor using piezoelectric and 
magnetostrictive materials, it will be possible to apply it coil-
lessly or wirelessly depending on the application or situation. 
Combining with soft materials may solve the brittleness of 
piezoelectric element and the eddy current of magnetostrictive 
materials (see Table  1). Furthermore, taking advantage of the 
characteristics of composite layered materials, it will be possible 
to develop biosensors that detect multiple viruses simultaneous-
ly. Material/structure optimization can be achieved by numeri-
cal simulations accounting for material and geometric nonlin-
earities, heterogeneous microstructure and complex shapes.
In recent years, some new methods have been developed 
that can detect SARS-CoV-2, as shown in Figure 19a.[133] A new 
assay device for identifying both SARS-CoV-2 and other winter 
viruses including influenza A has also been developed.[134] It 
was reported that it could successfully analyze DNA and detect 
SARS-CoV-2 within 90 min in nonclinical settings without the 
need for supervision by a trained healthcare professional. In 
addition, the detection of SARS-CoV-2 in air has been inves-
tigated (Figure  19b).[135] It is estimated that IoT and artificial 
intelligence (AI) will have huge economic impacts by 2030 
and will be increasingly in demand in the coming “postcorona 
Table 6. Comparison of virus sensor technologies.
Material Method Virus type Detection limit Detection range Detection time Advantage Disadvantage/future 
work
Ref.










QCM-D DENV NS-1 0.1 μg mL−1 0.01–10 μg mL−1 More sensitive, fast and less 
expensive diagnostic assays
[78]
QCM HIV-1 2 ng mL−1 Easy preparation; high sta-
bility and sensitivity
[88]
QCM HIV-1 1 ng mL−1 Low concentration limit [90]
QCM-D HBV ≈4.0 × 1012 mol-
ecules cm−2
Without the need of ampli-
fication steps or labeling 
methods
Fabrication of biosen-
sors able to detect in a 
single-step process
[93]
LiTaO3 SAW Ebola 1.9 × 104 PFU mL−1 1.6 × 104 to 6.5 × 
106 PFU mL−1
Adaptable, label-free and 
rapid detection
Portability and optimi-
zation for field use
[81]




87 TCID50s for 
HIV-2
5 min Rapid and accurate detection Testing the clinical sen-
sitivity and specificity 
using larger cohorts of 
infected patient sera 
in blinded case-control 
studies
[89]
SiO2/LiNbO3 SAW Influenza A H1N1 1 ng mL−1 Without compensation 




Influenza A 105 virions mL−1 15 min Acceptable detection time; 







0.1 ng mL−1 0.1–10 000 ng mL−1 Less than 2 h Simultaneously detect eight 
different analytes




PMN-PT Piezoprobe DNA HBVDM 60 copies mL−1 30 min [94]
Piezoprobe DNA HBVDM; KRAS As low as 
10−16 mol m−3




Metglas Magnetostriction CSFV 0.6 μg mL−1 Resonance frequency shift 
linearly proportional to 
CSFV concentration; simple 
circuit design; fast signal 
processing; visual liquid 
crystal display
[124]
Magnetostriction CSFV E2 2.466 ng mL−1 Several min US$ 0.001 per sensor; 
minimum skill; smaller size
[125]
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Figure 18. Magnetoelectric nanoparticles and their magnetic properties. a) Illustration of the basic configuration of multiferroic nanostructures. 
P and M are polarization and magnetization, respectively, and E and H are the respective electric and magnetic field intensities. b) TEM image of 
CoFe2O4–BaTiO3 composite. a,b) Reproduced with permission.[127] Copyright 2019, Cold Spring Harbor Laboratory Press.
Figure 19. a) Developed methods for detection of novel coronavirus SARS-CoV-2. b) Sampling and detection of coronaviruses in air. a) Reproduced under the 
terms of the CC-BY Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0).[133] Copyright 2020, The Authors, 
published by  John Wiley & Sons Australia, Ltd and Shanghai Fuji Technology Consulting Co., Ltd. b) Reproduced with permission.[135] Copyright 2020, Elsevier.
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society.” For example, IoT-connected biosensors with AI may 
become ubiquitous.[136,137] Along similar lines, Figure  20a 
shows a proposed mobile health system. This system can be 
used for patient health monitoring with a constant recording 
and feedback approach, but it can also be extended to track and 
trace infections for public health protection.
Currently, the development of efficient and reliable piezo-
electric and magnetostrictive based biosensors that detect 
SARS-CoV-2 is desired. In fact, the detection of SARS-CoV 
using the piezoelectric immunosensor has been reported,[138] 
and implementation of the recently proposed surface chem-
istry on the quartz crystal surface of the QCM will allow the 
early detection of SARS-CoV-2 (see Figure 21a,b).[139] Explora-
tion to implement these engineered surfaces on the MSMC 
surface is needed (Figure 21c). Both piezoelectric and magne-
tostrictive materials are also promising candidates for energy-
harvesting from ambient environmental sources to self-power 
biosensors for virus detection and communication. Such an 
advance would open a novel avenue for autonomous, digi-
talized virus detection. It is desirable to integrate wearable 
biosensors with energy-harvesters as self-powering sources. 
Such multifunctional self-powered sensing systems can poten-
tially manage health by automatically accumulating and trans-
mitting data, contributing greatly to the realization of a society 
in which people can live without fear of infection by various 
viruses. Figure 20b shows an example of such a future society. 
The connected IoT biosensor detects viral pathogens in the 
air. From the big data provided by numerous IoT biosensors, 
the spread of infection can be understood in real time, and 
its short-term and long-term impacts both locally and glob-
ally can be modeled in real time. Wearable actuators may be 
able to direct people in hazardous areas to escape. The power 
used may be harvested from the breeze flowing[23] through the 
air conditioning duct for 24 h in case of houses and under-
ground malls. AI can potentially predict a disease’s degree of 
spreading and severity. It is necessary for material researchers 
to cooperate with researchers from electrical/electronics and 
computer science fields to advance interdisciplinary investiga-
tion and better protect communities from various infectious 
diseases.
Figure 20. a) Proposed mobile health system. b) Proposed future society. a) Reproduced with permission.[136] Copyright 2020, The Science and Infor-
mation Organization.
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5. Concluding Remarks
Herein, we have  systematically summarized and reported pro-
gress in piezoelectric and magnetostrictive materials applied to 
biosensors. Based on the published literature we collected, these 
materials show great potential to be used in the detection of various 
infectious viruses. In particular, sampling and detection of corona-
virus in the air were discussed and are currently under intensive 
investigation. The intention of the article is to guide and assist 
material researchers to reexamine the design and performance of 
existing piezoelectric and magnetostrictive biosensors. It is hoped 
that the study will inform and assist these researchers to develop 
more effective and reliable sensors for virus detection with higher 
sensitivity and accuracy (ng per mL), smaller size and weight, and 
affordability, for home application or wearability in the near future 
(smart clothing). Such virus detection sensors will become reality 
with the further development of materials science and technolog-
ical progress in AI, machine learning and data analytics.
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